Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.

Abstract

PURPOSE To determine the prevalence of secondary causes of bone loss among patients with breast cancer with osteopenia and osteoporosis. PATIENTS AND METHODS All women referred to a bone health clinic over a 6-year period for bone evaluation were included in this retrospective study and stratified based on presence or absence of a breast cancer history. The prevalence of secondary causes of bone loss in the two groups was compared. RESULTS Of the 238 women identified, 64 women had breast cancer. The non-breast cancer group (n = 174) was significantly older (P = .015), had a lower mean weight (P = .019), lower 25 hydroxy-vitamin D level (P = .019), and greater degree of bone loss in both the spine and hip (P < .001 and 0.004, respectively). The presence of at least one secondary cause of bone loss, excluding cancer-related therapies, was seen in 78% of the breast cancer patient group and in 77% of the non-breast cancer group (P = not significant). Newly diagnosed metabolic bone disorders were seen in 58% of the breast cancer population. The most common was vitamin D deficiency, seen in 38% of patients in the breast cancer group and 51% of patients in the non-breast cancer group. Idiopathic hypercalciuria was diagnosed in 15.6%, primary hyperparathyroidism in 1.6%, and normocalcemic hyperparathyroidism in 3.1% of the breast cancer population. CONCLUSION A high prevalence of secondary causes of bone loss among patients with breast cancer supports a comprehensive evaluation in these patients, particularly those considering therapy with an aromatase inhibitor.

DOI: 10.1200/JCO.2008.17.7451

4 Figures and Tables

Statistics

0204060200920102011201220132014201520162017
Citations per Year

103 Citations

Semantic Scholar estimates that this publication has 103 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Camacho2008PrevalenceOS, title={Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.}, author={Pauline M. Camacho and Amit S Dayal and Josefina L Diaz and Fadi Nabhan and Monica D. Agarwal and John G Norton and Patricia A. Robinson and Kathy S. Albain}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2008}, volume={26 33}, pages={5380-5} }